tbuckley/cabot-search huggingface dataset:
Outcomes with MEK Inhibitor Therapy Among Adults with Langerhans Cell Histiocytosis (LCH): A Multi-Institutional Study from the Adult LCH Working Group for the Histiocyte Society
Authors: Gaurav Goyal, Aldo Adrian Acosta Medina, Xinxin Cao, Dana Bossert, Matthew P. Collin, Polyzois Makras, Omar Abdel-Wahab, Jithma Prasad Abeykoon, Rodothea Amerikanou, Corrie Bach, N. Nora Bennani, Benjamin Heath Durham, Jasmine H Francis, C Christopher Hook, Min Lang, Mario Lacouture, Kseniya Petrova-drus, Karen L Rech, Veronica Rotemberg, Gordon J Ruan, Mithun V Shah, Mariko Yabe, Jason R Young, Saurabh Zanwar, Ronald S. Go, Eli L. Diamond
Journal: Blood (2023)
Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study
Authors: Amy E. DeZern, Johannes Goll, Travis L Jensen, Sridhar N Srivatsan, Nancy K Gillis, Gregory A Abel, Eric Padron, H. Joachim Deeg, Tareq Al Baghdadi, Jane Lijun Liu, Rami S. Komrokji, Steven D. Gore, Wael Saber, Rafael Bejar, Matthew J. Walter, Seth Sherman, Nancy DiFronzo, Mikkael A. Sekeres
Journal: Blood (2023)
Preliminary Outcomes of Orelabrutinib Plus R-CHOP in Treatment-Naive Patients with Double-Expression Diffuse Large B-Cell Lymphoma
Authors: Yang Yang, Jingsong He, Yi Zhao, Wenjun Wu, Gaofeng Zheng, Xiaoyan Han, Donghua He, Tao Cheng, Zhen Cai
Journal: Blood (2023)
Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)
Authors: Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Sudeshna Dhar, Sandeepa Shetty, Mani Bharathi T.I., Anne Roshan Joseph, Gowri Shankar Krishnan, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Rahul Nahar, Lakshmikanth Gandikota, Anil Kamat
Journal: Blood (2023)
Early Post-Infusion Clearance of High-Dose Methotrexate Predicts Delayed Methotrexate Elimination and Acute Kidney Injury
Authors: Carmelo Rizzari, Nicolás Tentoni, Ryan Combs, Jennifer Lowe, Miriam Hwang, Thais Murciano, María Dolores Aumente, Teresa López-Viñau López, Scott C. Howard
Journal: Blood (2023)
Lymphoid Malignancies in Shwachman-Diamond Syndrome: Incidence, Clinical Features, and Outcomes from the North American SDS Registry
Authors: Helen D Reed, Hyunwoo Do, Edie Weller, Jason E Farrar, Christopher Gamper, Bonnie W Lau, Lauren Pommert, Ian Atkinson, Margret Joos, Sara Loveless, Sarah Steltz, Kasiani Myers, Akiko Shimamura
Journal: Blood (2023)
Combined Deficiency of Chromosome 7 Myeloid Tumor Suppressors Enhances Chemotherapy Resistance
Authors: Matthew R. M. Jotte, Tanner C. Martinez, Angela Stoddart, Molly K. Imgruet, Henna S. Nam, Bonnie Hu, Saira Khan, Ningfei An, Megan E. McNerney
Journal: Blood (2023)
Levofloxacin to Prevent Bacterial Infection in Patients with Acute Myeloid Leukemia Treated By Azacitidine and Venetoclax: A Study from the Dataml Registry
Authors: Xavier Brousse, Nicolas Rasandisona, Harmony Leroy, Karen Delavigne, Nathan Mottal, Suzanne Tavitian, Thibaut Leguay, Leopoldine Lapierre, Eric Delabesse, Audrey Bidet, Martin Gauthier, Diane Lara, Claire Calmettes, Audrey Sarry, Noemie Gadaud, Benoit Branco, anne-Charlotte de Grande, Clementine Beranger, Christian Recher, Arnaud Pigneux, Sarah Bertoli, Pierre-Yves Dumas
Journal: Blood (2023)
Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients with Ph+ Acute Lymphoblastic Leukemia Receiving First-Line Therapy
Authors: Ajibade Ashaye, Yves Chalandon, Hervé Dombret, Katherine Fazioli, Bingxia Wang, Ibrahim Aldoss, Fei Huang, Jessica T. Leonard, Nora Szabo, Conor McCloskey, Sunita Nair, Mehul Dalal, Meliessa Hennessy, Tammie Yeh, Talha Badar, Hagop Kantarjian, Josep-Maria Ribera, Elias Jabbour
Journal: Blood (2023)
Multicenter Evaluation of the Hemostatic Activity of Emicizumab in Patients with Severe Hemophilia a Using Thrombin Generation Assay
Authors: Laurie Josset, Maissaa Janbain, Annaelle De Wreede, Christophe Nougier, Stephanie Desage, Anne Lienhart, Xavier Delavenne, Yesim G. Dargaud
Journal: Blood (2023)
Chimeric Antigen Receptor T Cell Therapies Clinical Trials in Pediatric Oncology: A Retrospective Analysis from Clinicaltrials.Gov
Authors: Fabio Samir Vargas Cely, David A. Martinez, Juan Garcia Robledo, Pedro Franco-Fuquen, Rhea Hans, Eider Moreno-Cortes, Daniela A Castro Martinez, Januario E. Castro
Journal: Blood (2023)
Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study
Authors: JUN MA, Tiejun Gong, Donglu Zhao, Xiaoyu Zhu, Xiaojing Yan, Junjie Ma, Yun Cai, HongXiang Wang, Mei Hong, Li Liu, Qiang Song, Xin Wang
Journal: Blood (2023)
Combining Selinexor with R-CHOP in the Treatment of Newly Diagnosed High-Risk (IPI 3-5) GCB Subtype DLBCL Patients: A Multicenter, Open Label Phase 2 Study
Authors: Zhiming Li, Hang Yang, Yanxue Yin, Yajun Li, Xue Gao, Peng Sun, Yu Wang, Lu Zhang, Hui Zhou, Keshu Zhou, Jay Mei
Journal: Blood (2023)
Longitudinal PET/CT Imaging with Iodine ( 124I) Evuzamitide Reveals Organ Response to Plasma Cell Immunotherapy in a Patient with AL Amyloidosis
Authors: Ronald H. Lands, Emily B Martin, Dustin Powell, Alan Stuckey, Bryan Whittle, Renju Raj, Anne Kassira, Stephen J. Kennel, Jonathan S. Wall
Journal: Blood (2023)
Survival Outcomes in Patients with Intermediate and High-Risk Pulmonary Embolism Treated with Low Molecular Weight or Unfractionated Heparin: Time to Start of Anticoagulant Therapy
Authors: Kelsey E. Bria, Brian F. Gage, Serena Flórez Marqués, Melissa Beasley, Kim Kramer, Maanasi Samant, Nathan Droz, Kristen M. Sanfilippo
Journal: Blood (2023)
Development of Novel Invariant TCR-Anchored Bispecific Engagers to Enhance Anti-Cancer Activity of iNKT Cells
Authors: Klesti Karaxhuku, Kanagaraju Ponnusamy, Hongwei Ren, Bryan Lye, Ilia Leontari, Mehmood Zaidi, Farah Sabrin, Marco Bua, Maria Atta, Alexia Katsarou, Irene Roberts, Aristeidis Chaidos, Anastasios Karadimitris
Journal: Blood (2023)
Germline Variant in <i>ZCCHC8</i> Is Associated with Pulmonary Fibrosis, Bone Marrow Failure, Liver Inflammation, Early Grey Hair and Short Telomer Length
Authors: Nikolaj Juul Nitschke, Anne Marie Jelsig, Mette Klarskov Andersen, Kirsten Grønbæk
Journal: Blood (2023)
Enhanced Cardiovascular Risk Assessment Incorporating Natural Language Processing and Qrisk-3 Score Determination in Patients with Essential Thrombocythaemia
Authors: Patrick Harrington, Andrea Duminuco, Joshua Au Yeung, Sukhraj Singh Virdee, Raj Vaghela, Susan Asirvatham, Rosemarie Bone, Claire Woodley, Kyaw Htin Thaw, Llywelyn Cadman-Davies, Jennifer O'Sullivan, Priya Sriskandarajah, Natalia Curto-Garcia, Shahram Kordasti, Hugues de Lavallade, Deepti H. Radia, James Teo, Claire N Harrison
Journal: Blood (2023)
Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms
Authors: Marco Gabriele Raddi, Angela Consagra, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Giorgio Mattiuz, Sven De Pourcq, Elena Tofacchi, Maria Diez-Campelo, Juan Carlos Caballero Berrocal, Sophie Park, Mathieu Meunier, Celia Orlando, Michaela Fontenay, Olivier Kosmider, Nicolas Chapuis, Uwe Platzbecker, Katharina Zoldan, Anne Sophie Kubasch, Valeria Santini
Journal: Blood (2023)
Cold Agglutinin Disease (CAD) Real-World Evidence (CADENCE) Registry: Update to the Study Design of the First International, Prospective CAD Registry
Authors: Alexander Roeth, Wilma Barcellini, Ulrich Jaeger, Yasutaka Ueda, Marc Michel, Quentin A. Hill, Shruti Srivastava, Ronnie Yoo, Catherine M. Broome
Journal: Blood (2023)
A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)
Authors: Emma Seaford, Nicole Scobie, Lia Gore, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Catherine M. Bollard, Karin Mellgren, Carl Allen, Anne Auperin, Victoria Buenger, Pamela R. Kearns, Anna Lawson, Ellie Williams, Shanna Maycock, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood (2023)
Deep and Durable Cytogenetic and Molecular Responses with Pemigatinib in Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement: The Fight-203 Study
Authors: Andreas Reiter, Jean-Jacques Kiladjian, Jay L. Patel, William Shomali, Alessandro Rambaldi, Srdan Verstovsek, Stephen Oh, Kensuke Usuki, Claire N Harrison, Ellen K. Ritchie, Luke P. Akard, Juan Carlos Hernandez Boluda, Françoise Huguet, Natalia Oliveira, Huiling Zhen, Tracy I. George, Philomena Colucci, Aidan Gilmartin, Jason Gotlib, Alessandro M. Vannucchi
Journal: Blood (2023)
Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups
Authors: Elizabeth A. Brem, John M. Burke, Mirko Vukcevic, Pia Kloepfer, Kimberly Saverno, Haifaa Abdulhaq, Andrew M Evens, Pierluigi Porcu, Mazyar Shadman, Christopher R. Flowers
Journal: Blood (2023)
Notable Efficacy of Co-Treatment with FHD-286, a Dual BRG1/BRM ATP-Ase Inhibitor, and Menin or BET Inhibitor, Decitabine or Venetoclax Against AML with MLL-r or Mutant NPM1
Authors: Warren C. Fiskus, Jessica Piel, Murphy Hentemann, Christopher Peter Mill, Christine Birdwell, Kaberi Das, John Davis, Hanxi Hou, Noor Alhamadani, Kevin Philip, Alicia Matthews, Tapan M. Kadia, Naval Daver, Sanam Loghavi, Branko Cuglievan, Courtney D. DiNardo, Kapil N. Bhalla
Journal: Blood (2023)
Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID)
Authors: Edo Schaefer, Christine Vu, Allyson Flower, Janet Ayello, Yaya Chu, Carmella Van De Ven, Elizabeth Mintzer, Lauren Harrison, Erin Morris, Yongping Wang, Shalini Shenoy, Dean Anthony Lee, Rolla ABU-Arja, Bryon D. Johnson, Michael R Verneris, Christopher C Dvorak, Julia Chu, Kenneth R. Cooke, Julie-An Talano, Nancy Bunin, Mitchell S. Cairo
Journal: Blood (2023)
The Value of Collaboration with Patient Advocacy Organizations to Enhance Initiatives Focused on Patient-Centered Care and Improve Outcomes in Chronic Lymphocytic Leukemia
Authors: Carmine Deluca, Michael Beyer, Heather Drew, Jeffrey Murray, Jessica Massey, Brian Koffman, Kristen Battiato, John G. Gribben, Nicole Lamanna, Christina Russomanno
Journal: Blood (2023)
Type 1/like <i>Calr</i> Mutation in Momelotinib-Treated Patients with Myelofibrosis Is the Most Prominent Predictor of Drug Survival and Longevity without Transplant
Authors: Ayalew Tefferi, Animesh D. Pardanani, Kebede Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Naseema Gangat
Journal: Blood (2023)
A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia between Appalachian and Non-Appalachian Kentucky
Authors: Zena Chahine, Xitong Zhou, Anna Johnson, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Chaitanya Iragavarapu, Gregory Monohan, Reinhold Munker, Fevzi Yalniz, Ayman Qasrawi, Reshma Ramlal
Journal: Blood (2023)
The Clinical Significance and Prognostic Value of Serum Beta-2 Microglobulin in Adult Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Multicenter Analysis of 326 Patients
Authors: Wenyu Shi, Yi Miao, Ze Jin, Jie Zhang, Jing Zhang, Chunling Wang, Xuzhang Lu, Yuqing Miao, Sun Miao, Yunping Zhang, Yun Zhuang, Haiwen Ni, Jingyan Xu, Min Zhao, Wanchuan Zhuang, Jianfeng Zhu, Min Xu, Guoqing Lin, Haiying Hua, Xiaoyan Xie, Maozhong Xu, Tao Jia, Lijia Zhai, Weiying Gu, Qiurong Shan, Zhi Wang, Qiudan Shen, Bingzong Li, Jianyong Li
Journal: Blood (2023)
Targeting the Oncofetal Transcription Factor Protein SALL4 in Cancer By a Non-IMiD Degrader
Authors: Kim Anh L. Vu, Kalpana Kumari, Bee Hui Liu, Chong Gao, Feng Li, Jing Ping Tang, Danilo Maddalo, Xi Tian, Miao Liu, Mahmoud Adel Bassal, Shiva Moein, Viktoriia Iakovleva, Justin L. Tan, Alicia J. Stein, Qiling Zhou, Patrick D. Fischer, Logan H. Sigua, Jun Qi, Haribabu Arthanari, Daniel G. Tenen, Li Chai
Journal: Blood (2023)
High Body Mass Index Is Associated with Favorable Outcome in Younger Patients Receiving CD19 CAR T-Cell Therapy for B-Cell Lymphoma: A Retrospective Study from the EBMT Transplant Complications Working Party
Authors: Christian R. Schultze-Florey, Christophe Peczynski, William Boreland, Michael Daskalakis, Anne Sirvent, Ibrahim Yakoub-Agha, Maria-Luisa Schubert, Christof Scheid, Anne Huynh, Victoria Potter, Didier Blaise, Matthew P. Collin, Rafael Hernani, Gerald G. Wulf, Francis A. Ayuk, Caroline Besley, Lucia Lopez Corral, Edouard Forcade, Peter Vandenberghe, Dominik Schneidawind, Matthias Stelljes, Friedrich Stölzel, Bertram Glass, Ivan Sergeevich Moiseev, Helene Schoemans, Olaf Penack, Christian Koenecke, Zinaida Peric
Journal: Blood (2023)
Incremental Healthcare Resource Utilization and Costs Associated with Non-Optimal Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKI) in Early Lines of Therapy in the United States (US)
Authors: Vamsi K. Kota, David Wei, Daisy Yang, Hela Romdhani, Dominick Latremouille-Viau, Annie Guérin, Kejal Jadhav
Journal: Blood (2023)
Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Huili Zhu, Xingyu Cao, Yue Lu, Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Ruijuan Sun, Hongxing Liu, Zhijie Wei
Journal: Blood (2023)
ELN Treatment Milestones in Chronic Myeloid Leukemia Are Prognostic for Achieving Deep Molecular Response and Treatment-Free Remission in Routine Care: Results of the German CML Registry
Authors: Katharina Kohlbrenner, Norbert Galuschek, Alice Fabarius, Marcel Reiser, Klaus Fenchel, Eva Esseling, Thomas Göhler, Ralf-Bodo Kühn, Reinhard Depenbusch, Ivo Talah Azeh, Erik Engel, Richard Hansen, Mathias Hanel, Paul Jehner, Maisun Abu-Samra, Markus Ritter, Norbert Gattermann, Henning Pelz, Stefan Fuxius, Burkhard Oswald, Gabriela M Baerlocher, Tim H. Brümmendorf, Dominik Heim, Philipp le Coutre, Andreas Burchert, Dietger Niederwieser, Hans Tesch, Wolf-Karsten Hofmann, Andreas Hochhaus, Rüdiger Hehlmann, Susanne Saussele
Journal: Blood (2023)
Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image
Authors: Julia A. O'Brien, Charles R. Jonassaint, Christina M. Lalama, Sherif M. Badawy, Megan E. Hamm, Jennifer Stinson, Chitra Lalloo, Christopher Patrick Carroll, Santosh L. Saraf, Victor R. Gordeuk, Robert Cronin, Nirmish Shah, Sophie Lanzkron, Darla K. Liles, Leshana Saint-Jean, Michael R. DeBaun, Cassandra Trimnell, Lakiea Bailey, Raymona Holloway Lawrence, Laura M. Decastro, Tonya Palermo, Kaleab Abebe
Journal: Blood (2023)
Olutasidenib Alone or in Combination with Azacitidine Induces Durable Complete Remissions in Patients with <i>mIDH1</i> Myelodysplastic Syndromes/Neoplasms (MDS)
Authors: Jorge Cortes, Jay Yang, Sangmin Lee, Shira N. Dinner, Eunice S. Wang, Maria R. Baer, William B. Donnellan, Justin M. Watts
Journal: Blood (2023)
Automated Cut&amp;run Brings Scalable Epigenomic Profiling to Hematology
Authors: Keith E Maier, Matthew R Marunde, Vishnu U. Sunitha Kumary, Carolina P Lin, Danielle N Maryanski, Liz Albertorio-Saez, Dughan J Ahimovic, Michael J Bale, Juliana J Lee, Bryan J Venters, Michael-Christopher Keogh
Journal: Blood (2023)
Truncating <i>SPEN</i> Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion
Authors: Janek S. Walker, Kerstin Wenzl, Joseph P. Novak, Michelle Manske, Makayla Serres, Allison M. Bock, Melissa A. Hopper, Jordan Edward Krull, Abigail R. Dropik, Miranda S. Laverty, Vivekananda Sarangi, Matthew J. Maurer, Lisa M. Rimsza, Brian K. Link, Thomas M. Habermann, Rebecca L. King, Stephen M Ansell, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak
Journal: Blood (2023)
The Histopathological Landscape of Synovitis in Hemophilic Arthropathy
Authors: Roberta Gualtierotti, Chiara Suffritti, Carlo Pescia, Andrea Giachi, Silvia Spena, Federico Molfino, Stanislao Lavorato, Eleonora Semproni, Addolorata Truma, Sara Arcudi, Alessandro Ciavarella, Marco Maggioni, Umberto Gianelli, Simona Maria Siboni, Jacopo Acquati Lozej, Luigi Piero Solimeno, Flora Peyvandi
Journal: Blood (2023)
Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study
Authors: Catherine C. Coombs, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel, Toby A. Eyre, Constantine S. Tam, John F. Seymour, Nirav N. Shah, Ian W. Flinn, Chan Y. Cheah, Shuo Ma, Joanna M. Rhodes, Koji Izutsu, Wojciech Jurczak, William G. Wierda, Angely Loubert, Nalin Payakachat, Lisa M. Hess, Paolo Abada, Nicole Lamanna
Journal: Blood (2023)
Increased Circulating 2-Methylbutyrate Following Fecal Microbiota Transplantation in Patients with Refractory-Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Authors: Jing Du, Fen Huang, Kaibo Yang, Na Xu, Zhiping Fan, Li Xuan, Qifa Liu
Journal: Blood (2023)
Novel Hypomethylating Agent Ntx-301 Exhibits Anti-Leukemia Activity in Venetoclax-Resistant and TP53-Mutant AML
Authors: Bing Z. Carter, Po Yee Mak, Baozhen Ke, Andrea Bedoy, Steffen Boettcher, Lauren B. Ostermann, Elizabeth J. Shpall, Michael Andreeff
Journal: Blood (2023)
Molecular Profiling of Response and Resistance to Venetoclax-Decitabine Therapy in Acute Myeloid Leukemia
Authors: Abdullah Khasawneh, Faith Jessica Paran, Rieko Oyama, Abhishek Maiti, Hussein A Abbas, Bofei Wang, Poonam N Desai, Kala Hayes, Joe R Harman, Xiaoping Su, Courtney D. DiNardo, Michael Andreeff, Thomas A Milne, Marina Y. Konopleva, Yoko Tabe
Journal: Blood (2023)
Permissibility of an Intermittent Fasting in Patients with Chronic Lymphocytic Leukemia in the Era of Novel Therapies :a Pharmacology Based Review
Authors: Maria Benkhadra, Nuha Fituri, Soha Aboukhalaf, Rola Ghasoub, Mervat Mattar, Khalil Al Farsi, Salem Alshemmari, Mohamed A Yassin
Journal: Blood (2023)
Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia
Authors: Jeff P. Sharman, Jan A. Burger, Jacqueline Barrientos, Philip Kuruvilla, Sima Patel, Gabriel Krigsfeld, Sowmya Srikanthan, Bothayna Messahel, Wasiulla Khan, Emma Smith, Paolo Ghia
Journal: Blood (2023)
A Matching-Adjusted Indirect Comparison of Acalabrutinib with and without Obinutuzumab Versus Zanubrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia
Authors: John N. Allan, Adam S Kittai, Dan James, Helen Ridge, Miguel Miranda, Alan Yong, Fady Fam, Jack Roos, Vikram Shetty, Matthew S. Davids, Alan Skarbnik
Journal: Blood (2023)
Improving Transition of Emerging Adults with Sickle Cell Disease to Adult Care through a Multidisciplinary Process: The Development of a Transition Clinic to Support Transition Success
Authors: Lynette Fenchel, Felisha Jackson, Brittany Walker, Chandra Manuel, Dajia Hooks, Tyesha Allen, Mamie Myo Thant, Kristine Karkoska, Luke R. Smart, Naomi E Joffe, Omar Niss
Journal: Blood (2023)
Propensity Score Matching Comparing Asciminib <i>Versus</i> Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy
Authors: Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Mary Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Mar Linn, Gopila Gupta, Emilia Scalzulli, Jiří Mayer, Peter E Westerweel, Dennis Dong Hwan Kim
Journal: Blood (2023)
In Vivo Modeling of T-Cell Acute Lymphoblastic Leukemia Reveals Synergistic Oncogenic Pathways and <i>Bcl11b</i> Haploinsufficiency As a Potential Therapeutic Vulnerability
Authors: Maximilian Schinke, Marc-Jens Kleppa, Dirk Heckl, Michael Heuser, Axel Schambach, Adrian Schwarzer
Journal: Blood (2023)
Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing
Authors: Maria D Rivera, Jessica Pham, Jane Isquith, Haoran Zhang, Jenny Zhou, Roman Sasik, Adam Mark, Wenxue Ma, Frida Holm, Kathleen Fisch, Dennis John Kuo, Catriona Jamieson, Qingfei Jiang
Journal: Blood (2023)
Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma
Authors: Arnon Haran, Noa Gros Even-Zohar, Eyal Lebel, Shlomzion Aumann, Adir Shaulov, Moshe E Gatt, Boaz Nachmias
Journal: Blood (2023)
Monocyte Subpopulations and Their Expression of HLA-DR and CD300e after Allogeneic Stem Cell Transplantation in Patients with or without GvHD
Authors: Igor Age Kos, Jörg-Thomas Bittenbring, Onur Cetin, Vadim Lesan, Konstantinos Christofyllakis, Frank Neumann, Lorenz Thurner, Moritz Bewarder
Journal: Blood (2023)
Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (&amp;lt;12 years) with Hemophilia a or B with Inhibitors
Authors: Steven Pipe, Johannes Oldenburg, Manuel Carcao, Meera Chitlur, Yesim Dargaud, Joanna Davis, Carmen Escuriola, Charles Hay, Cédric Hermans, Nina Hwang, Víctor Jiménez-Yuste, Craig Kessler, Johnny Mahlangu, Maria Elisa Mancuso, Catherine McGuinn, Wolfgang Miesbach, Tammuella Chrisentery-Singleton, Courtney Thornburg, Michael Wang, Daniel Bonzo, Ian Mitchell, Thomas Wilkinson, Amy Dunn
Journal: Blood (2023)
Chimeric Antigen Receptor-Engineered NK Cells Overcome CD226 Downregulation As an Immune Escape Mechanism in Acute Myeloid Leukemia
Authors: Luciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, Paul Lin, May Daher, MD, Hind Rafei, Bijender Kumar, Katayoun Rezvani
Journal: Blood (2023)
Impact of Psychological Distress on Immune Phenotype in CLL/SLL Patients Managed By Active Observation
Authors: Carolyn Y. Fang, Jakub Svoboda, Adam D. Cohen, Henry C. Fung, Richard I. Fisher, Elizabeth Handorf, Hatcher Ballard, Stefan K. Barta, Daniel J. Landsburg, Dwivedy S. Nasta, Stephen J Schuster, Rashmi Khanal, Alexander W. MacFarlane, Kerry S. Campbell
Journal: Blood (2023)
Safety and Feasibility of a 16-Week Progressive Exercise Intervention in Treatment Naïve Chronic Lymphocytic Leukaemia
Authors: Frankie F Brown, Rebecca Oliver, Adam J Causer, Harrison D Collier-Bain, Annabelle Emery, Rachel Eddy, David Dutton, Josephine Crowe, Daniel Augustine, John Graby, Dan Rees, Daniela Rothschild Rodriguez, Oliver Peacock, Sally Moore, James Murray, James E Turner, John P Campbell
Journal: Blood (2023)
Acalabrutinib in Chinese Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): 12-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial
Authors: Shenmiao Yang, Haiwen Huang, Keshu Zhou, Xielan Zhao, Yanqiu Han, Lindong Li, Anna Butturini, Yujie Wang, Xiaofeng Liu, Peiqiong Lai, Jianyong Li
Journal: Blood (2023)
Venetoclax Synergizes with IMGN632, a Novel CD123-Targeting Antibody Conjugated to a DNA Alkylating Payload, By Suppressing DNA Damage Response and Potentiating Apoptosis in Acute Myeloid Leukemia <i>in Vitro</i> Models
Authors: Anna Skwarska, Vinitha Mary Kuruvilla, Qi Zhang, Sovira Chaudhry, Naval Daver, Krystal Watkins, Callum Mortimer Sloss, Patrick A. Zweidler-McKay, Deepa Sampath, Marina Y. Konopleva
Journal: Blood (2023)
Correlation Revealed between Gemtuzumab-Ozogamicin Efficacy and CD33+ Expression in AML Primary Samples through a Novel AML in Vitro Model
Authors: Mara Gilardi, Garima Kaushik, Brandon Walling, Vaishnavi Sambandam, Paolo Schiavini, Stefano Cairo, Maria A. Zipeto, Michael Ritchie
Journal: Blood (2023)